1. French National Agency for the Safety of Medicinal Products (ANSM). Use of proton pump inhibitors (PPIs) observational study from SNDS data, France, 2015. 2018.https://www.epi-phare.fr/app/uploads/2020/04/EPI-PHARE_2018_utilisation_IPP.pdf. [Accessed 13 May 2024 (78 pp.)]
2. Long-term proton pump inhibitor therapy and risk of hip fracture;Yang;JAMA,2006
3. Proton pump inhibitors and fracture risk: a review of current evidence and mechanisms involved;Thong;Int J Environ Res Public Health,2019
4. Proton pump inhibitors and gastroenteritis;Hassing;Eur J Epidemiol,2016
5. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection: systematic review: proton pump inhibitors and bacterial diarrhoea;Bavish;Alim Pharmacol Ther,2011